What is the maximum oral dose of Klor‑Con (potassium chloride)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Oral Dose of Klor-Con

The maximum oral dose of Klor-Con (potassium chloride) is 200 mEq in a 24-hour period for adults, with individual doses limited to 40 mEq per dose. 1

Adult Dosing Guidelines

According to the FDA-approved prescribing information, the dosing parameters are clearly defined:

Treatment of Hypokalemia:

  • Daily dose range: 40-100 mEq
  • Divided into 2-5 doses throughout the day
  • Maximum single dose: 40 mEq
  • Maximum total daily dose: 200 mEq per 24 hours 1

Maintenance or Prophylaxis:

  • Typical dose: 20 mEq per day
  • Individualize based on serum potassium levels 1

Pediatric Dosing (Birth to 16 Years)

Treatment of Hypokalemia:

  • Initial dose: 2-4 mEq/kg/day in divided doses
  • Maximum single dose: 1 mEq/kg or 40 mEq (whichever is lower)
  • Maximum daily dose: 100 mEq 1

Maintenance or Prophylaxis:

  • Typical dose: 1 mEq/kg/day
  • Maximum: 3 mEq/kg/day 1

Critical Safety Considerations

Monitoring Requirements:

  • For severe hypokalemia (serum K+ <2.5 mEq/L), use intravenous potassium instead of oral supplementation 1
  • Monitor serum potassium daily or more frequently during treatment of hypokalemia until levels normalize
  • For maintenance therapy, monitor monthly to biannually 1
  • Monitor acid-base balance, volume status, and other electrolytes (magnesium, sodium, chloride, phosphate, calcium) 1

Administration Guidelines:

  • Dilute each 20 mEq packet in at least 4 ounces of cold water or other beverage
  • Take with meals or immediately after eating to reduce gastrointestinal irritation 1
  • Increased dilution and taking with meals may further reduce GI side effects 1

Risk of Hyperkalemia

In clinical studies of patients with CKD stage G3b-4, supplementation with 40 mmol (approximately 40 mEq) KCl daily for 2 weeks resulted in:

  • 11% of participants developing hyperkalemia (plasma K+ ≥5.5 mmol/L)
  • Mean plasma potassium increase of 0.4 mmol/L
  • Higher risk in older patients and those with higher baseline potassium levels 2

Contraindications:

  • Absolute contraindication: concurrent use of potassium-sparing diuretics 1
  • Exercise extreme caution with RAAS inhibitors (ACE inhibitors, ARBs, aldosterone antagonists) and NSAIDs, which increase hyperkalemia risk 1

Common Pitfalls to Avoid

  1. Never exceed 40 mEq per single dose - this is a hard ceiling regardless of total daily dosing needs
  2. Do not use oral supplementation when serum K+ <2.5 mEq/L - IV therapy is required 1
  3. Avoid underdilution - inadequate dilution significantly increases risk of GI irritation and ulceration
  4. Watch for drug interactions - particularly with RAAS inhibitors and NSAIDs which can precipitate dangerous hyperkalemia 1
  5. In overdose situations (case reports describe ingestions of 100-300 mEq), sustained-release tablets are visible on abdominal radiographs and whole-bowel irrigation may be effective 3

References

Research

Effects of Short-Term Potassium Chloride Supplementation in Patients with CKD.

Journal of the American Society of Nephrology : JASN, 2022

Research

Sustained-release potassium chloride overdose.

Journal of toxicology. Clinical toxicology, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.